comparemela.com

Latest Breaking News On - Cooper vision - Page 4 : comparemela.com

Cooper Companies (NYSE:COO) Given New $400 00 Price Target at Robert W Baird

Cooper Companies (NYSE:COO – Get Rating) had its price objective raised by Robert W. Baird from $385.00 to $400.00 in a research note released on Friday morning, The Fly reports. A number of other research firms have also issued reports on COO. Piper Sandler lifted their price objective on shares of Cooper Companies from $375.00 […]

Cooper Companies (NYSE:COO) Issues Quarterly Earnings Results, Beats Estimates By $0 04 EPS

Cooper Companies (NYSE:COO – Get Rating) posted its quarterly earnings results on Thursday. The medical device company reported $3.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.04 by $0.04, Briefing.com reports. The firm had revenue of $877.40 million during the quarter, compared to analyst estimates of $865.81 million. Cooper Companies […]

Picton Mahoney Asset Management Boosts Position in The Cooper Companies, Inc (NYSE:COO)

Picton Mahoney Asset Management boosted its holdings in The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 348.2% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 986 shares of the medical device company’s stock after buying an additional 766 shares during the period. Picton Mahoney Asset Management’s […]

Cooper Companies (NYSE:COO) Releases Earnings Results, Beats Estimates By $0 09 EPS

Cooper Companies (NYSE:COO – Get Rating) posted its earnings results on Thursday. The medical device company reported $3.08 earnings per share for the quarter, beating analysts’ consensus estimates of $2.99 by $0.09, Briefing.com reports. Cooper Companies had a return on equity of 8.39% and a net margin of 11.10%. The company had revenue of $877.40 […]

Cooper Companies (NYSE:COO) Research Coverage Started at Morgan Stanley

Morgan Stanley initiated coverage on shares of Cooper Companies (NYSE:COO – Get Rating) in a research note released on Tuesday morning, The Fly reports. The brokerage issued an equal weight rating and a $410.00 price objective on the medical device company’s stock. A number of other equities analysts have also recently issued reports on the […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.